Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl inhibitor -
B2284 Fostamatinib (R788)1 CitationTarget: SykSummary: Spleen tyrosine kinase (Syk) inhibitor -
B1439 Golvatinib (E7050)Target: VEGFRSummary: C-Met/VEGFR-2 inhibitor -
B1495 OSI-420 free baseSummary: EGFR inhibitor -
B2303 Apatinib mesylate4 CitationSummary: VEGFR2 inhibitor, orally bioavailable, selective -
B1020 AST-1306 TsOHSummary: ErbB2 and EGFR inhibitor -
B1262 HG-10-102-011 CitationTarget: LRRK2Summary: LRRK2 inhibitor -
B6097 SU56141 CitationSummary: tyrosine kinase inhibitor -
B6158 RO9021Summary: Syk inhibitor -
B6161 PRT-060318Summary: novel Syk inhibitor
